Pharma Distribution Giant Cardinal Health Lifts 2025 Guidance After Q4 Earnings Beat, Raises Stock Buyback Expectation By $250M
Portfolio Pulse from Vandana Singh
Cardinal Health Inc (NYSE:CAH) reported strong Q4 2024 earnings, beating expectations with a 29% increase in adjusted EPS and a 12% rise in sales. The company raised its fiscal year 2025 guidance and increased its stock buyback program by $250 million.
August 14, 2024 | 12:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cardinal Health reported a strong Q4 2024 with a 29% increase in adjusted EPS and a 12% rise in sales, beating consensus estimates. The company raised its fiscal year 2025 guidance and increased its stock buyback program by $250 million.
The strong Q4 earnings beat, increased guidance, and expanded stock buyback program are likely to positively impact CAH's stock price in the short term. The company's performance and strategic actions indicate strong future prospects.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100